Publications
Policing in Peace Operations in Africa: A Case Study of the United Nations Multidimensional Integrated Stabilization Mission in Mali (MINUSMA)
Locating international REDD+ power relations: Debating forests and trees in international climate negotiations
Cyber Security Capacity Building : Developing Access
This study concentrates on providing the rationale and identifying potential ‘dimensions’ for certain governmental CCB instruments, and what tasks they should cover. The ‘methodological’ dimension includes developing frameworks for assessing and delivering CCB programmes, but also extends to general frameworks for supporting a country’s national cyber security strategy as well as the basic research needed. The ‘technical’ dimension is concentrated on the need to train and support the Computer Emergency Response Team (CERT) and law enforcement capabilities of partner countries. In fact, such initiatives had already been ongoing for many years before the term ‘CCB’ was coined. Thirdly, the existence of ‘infrastructure’ development programmes has long been a feature of international development, albeit without much focus on security concerns. Fourthly, the instrument of overall ‘budgetary support’ can be used for directly funding partner countries’ operational expenses in issues related to cyber security over a prolonged period. The study concludes with some recommendations for policy-makers
Heads of States Can Change the Course of International Drugs Policy in 2016: Where does the EU stand?
A quick overview of the past ten to fifteen years developments in drugs policies in Europe reveals two diverging trends: a public health and social policy track on the one hand, and a security policy track on the other. While as the future of drugs policy as a political field in its own right is being questioned in the European context, the EU has explicitly stated its objective of a greater involvement and role in international drugs policy. Apart from continuity in harm reduction and research promotion – i.e., EU’s key contributions to global drugs policy – EU support to larger and deeper reconfigurations of the global drug prohibition regime remains highly unlikely.